THE EVOLVING DEMANDS FOR MEDICAL DEVICE EVIDENCE DEVELOPMENT- WHAT THE FUTURE HOLDS
Author(s)
Moderator: Meike Bomhof, -, Sr. Vice President Europe, Global Headquarters, Rockland, MA, USA
Panelists: Rachele Busca, PharmD, MSc, MBA, EMEA Leader, Health Economics, W.L GORE, Verona, Italy; Lindsay Bockstedt, PhD, Vice President, Global Health Economics and Outcomes Research, Medtronic, Minneapolis, MN, USA; Hedi Schelleman, PhD, Advisor and Research Programme Officer, The National Healthcare Institute (ZIN), Diemen, Netherlands; Rossana Alessandrello, MSc, Public Procurement Coordinator, Agency for Health Quality and Assessment of Catalonia (AQuAS), Barcelona, Spain
Presentation Documents
This expert panel will review the latest issues in medical device evidence requirements, with discussion of several case study examples. Key issues to be addressed include the evolution of EUnetHTA joint assessments and how they are applied by EU member countries, the impact of new CE mark-related evidence requirements, and how medical device firms should work to bridge the divide between country level requirements for Health Technology Assessment and regulatory study requirements. Panel will include HTA experts from national bodies, along with industry experts.
Conference/Value in Health Info
2019-11, ISPOR Europe 2019, Copenhagen, Denmark
Code
SP3